Deutsch English Français

Contact

EP2144930

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2144930

EP2144930 - SINGLE CHAIN FC, METHODS OF MAKING AND METHODS OF TREATMENT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 28.10.2011 Database last updated on 11.09.2024
Most recent event Tooltip	28.10.2011	Application deemed to be withdrawn	published on 30.11.2011 [2011/48]
Applicant(s)	For all designated states ZymoGenetics, Inc. 1201 Eastlake Avenue East Seattle, Washington 98102 / US
	[2010/03]
Inventor(s)	01 / MOORE, Margaret, D. 7771 57th Avenue NE Seattle, Washington 98115 / US
	02 / SNAVELY, Marshall, D. 15706 NE 136th Place Redmond, Washington 98052 / US
	03 / FOX, Brian, A. 3925 Woodlawn Avenue N. Seattle, Washington 98103 / US
	[2010/22]
Former [2010/03]	01 / MOORE, Margaret, D. 7771 57th Avenue NE Seattle, Washington 98115 / US
	02 / SNAVELY, Marshall, D. 15706 NE 136th Place Redmond, Washington 98052 / US
	03 / FOX, Brian, A. 3925 Woodlawn Avenue N. Seattle, Washington 98103 / US
	04 / HOYOS, Gabriela, H. 3939 SW Elmgrove Street Seattle, Washington 98136 / US
Representative(s)	MacLean, Martin Robert Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[N/P]
Former [2010/03]	MacLean, Martin Robert Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB
Application number, filing date	08780548.7	18.04.2008
	[2010/03]
	WO2008US60852
Priority number, date	US20070912647P	18.04.2007 Original published format: US 912647 P
	US20070914682P	27.04.2007 Original published format: US 914682 P
	[2010/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2008131242
	Date:	30.10.2008
	Language:	EN
	[2008/44]
	Type:	A1 Application with search report
	No.:	EP2144930
	Date:	20.01.2010
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 30.10.2008 takes the place of the publication of the European patent application.
	[2010/03]
Search report(s)	International search report - published on:	EP	30.10.2008
Classification	IPC:	C07K16/00, A61K39/395, A61P35/00, A61P37/00	[2010/03]
	CPC:	C07K16/32 (EP,US); A61P35/00 (EP); A61P37/00 (EP); A61P37/04 (EP); A61P43/00 (EP); C07K2317/41 (EP,US); (+) C07K2317/52 (EP,US); C07K2317/622 (EP,US); C07K2317/72 (EP,US); C07K2317/732 (EP,US); C07K2317/734 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/03]
Title	German:	EINZELKETTEN-FC SOWIE HERSTELLUNGSVERFAHREN DAFÜR UND BEARBEITUNGSVERFAHREN DAFÜR	[2010/03]
	English:	SINGLE CHAIN FC, METHODS OF MAKING AND METHODS OF TREATMENT	[2010/03]
	French:	FC À CHAÎNE SIMPLE, PROCÉDÉS DE FABRICATION ET PROCÉDÉS DE TRAITEMENT	[2010/03]
Entry into regional phase	16.11.2009	National basic fee paid
	16.11.2009	Designation fee(s) paid
	16.11.2009	Examination fee paid
Examination procedure	16.11.2009	Amendment by applicant (claims and/or description)
	16.11.2009	Examination requested [2010/03]
	16.02.2010	Despatch of a communication from the examining division (Time limit: M04)
	21.04.2010	Reply to a communication from the examining division
	22.11.2010	Despatch of a communication from the examining division (Time limit: M06)
	04.06.2011	Application deemed to be withdrawn, date of legal effect [2011/48]
	07.07.2011	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/48]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.02.2010
Fees paid	Renewal fee
	26.04.2010	Renewal fee patent year 03
	25.04.2011	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY]WO2005077981 (XENCOR INC [US], et al) [X] 1-11,13,32,33,37,38,43-46,52,61,63,64,66,67,72-78 * the whole document * [Y] 12,14-31,34-36,39-42,47-51,53-60,62,65,68-71,79;
		[Y]WO0246227 (LILLY CO ELI [US], et al) [Y] 12,14,15,18,19,27,28,34-36,62,65 * page 79 - page 85; example 6 *;
		[Y]WO2007038703 (ZYMOGENETICS INC [US], et al) [Y] 12,14,18,28,34,62,65 * sequences 175,180 *;
		[Y]WO2006076594 (XENCOR INC [US], et al) [Y] 12,14,18,28,34,62,65 * example 4; sequence 480 *;
		[Y]US2007071764 (SULLIVAN JOHN K [US], et al) [Y] 12,14,18,28,34,62,65 * sequence 83 *;
		[Y]WO0238766 (ZYMOGENETICS INC [US]) [Y] 12,14,18,28,34,62,65 * page 146 - page 149; example 4; sequences 28,32 *;
		[Y]WO9737029 (PROTEIN DESIGN LABS INC [US], et al) [Y] 16,17,26,27,29-31,41,42,50,51,58-60,70,71 * the whole document *;
		[Y]US6387371 (HUDZIAK ROBERT M [US], et al) [Y] 20,21,39,40,48,49,55-57,68,69,79 * the whole document *;
		[Y]US5807706 (CARTER PAUL J [US], et al) [Y] 22-25 * column 1 - column 11 *;
		[PX]WO2008012543 (UCB PHARMA SA [BE], et al) [PX] 1,2,5-10,13,22,32,33,37,43,52,61,64,66 * the whole document *;
		[X] - GREENWOOD J ET AL, "Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis", THERAPEUTIC IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBL. LONDON, GB, (19941001), vol. 1, no. 5, ISSN 0967-0149, pages 247 - 255, XP009059035 [X] 1-3,5,6,13,74,75 * page 248; figure 1 *
		[Y] - GERBER HANS-PETER ET AL, "Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, (20070227), vol. 104, no. 9, ISSN 0027-8424, pages 3478 - 3483, XP002481171 [Y] 26 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0611492104
		[Y] - KANEKO Y ET AL, "Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation", SCIENCE, WASHINGTON, DC, (20060801), vol. 313, no. 5787, ISSN 0036-8075, pages 670 - 673, XP008076047 [Y] 44-47,53,54,57,60 * the whole document * DOI: http://dx.doi.org/10.1126/science.1129594
		[Y] - JENKINS N ET AL, "Genetic Engineering of alpha2,6-sialyltransferase in recombinant CHO cells", BIOCHEMICAL SOCIETY TRANSACTIONS, COLCHESTER, ESSEX, GB, (19980501), vol. 26, no. 2, ISSN 0300-5127, page S115, XP009064116 [Y] 44-47,53,54,57,60 * the whole document *
		[PX] - NAGASHIMA H ET AL, "Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, vol. 45, no. 10, ISSN 0161-5890, (20080501), pages 2752 - 2763, (20080318), XP022605994 [PX] 1,2,5,6,13,32,33,43,52 * the whole document * DOI: http://dx.doi.org/10.1016/j.molimm.2008.02.003
	by applicant	WO2005077981
		WO0246227
		WO2007038703
		WO2006076594
		US2007071764
		WO0238766
		US6387371
		US5807706
		- RIDGWAY, "Knobs-into-holes' Engineering of Antibody Ch3 Domains for Heavy Chain Heterodimerization", PROTEIN ENGINEERING, (1996), vol. 9, no. 7, pages 617 - 621
		- CARTER, P., "Bispecific human IgG by design.", J. IMMUNOL. METH., (2001), vol. 248, pages 7 - 15
		- GREENWOOD J ET AL., THERAPEUTIC IMMUNOLOGY, (19941001), vol. 1, no. 5, pages 247 - 255

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p